|
On this page, you can select 「MainGroup」 or 「Facet」 in A61K. |
HB:Handbook | ||||
|
Select the desired 「MainGroup」 or 「facet」 etc. |
CC:Concordance | ||||
|
|
Preparations for dentistry | HB | CC | 4C089 | |
|
|
Cosmetics or similar toiletry preparations [2006.01] | HB | CC | 4C083 | |
|
|
Medicinal preparations characterised by special physical form | HB | CC | 4C076 | |
|
|
Medicinal preparations containing organic active ingredients [2] | HB | CC | 4C206 | |
|
|
Medicinal preparations containing inorganic active ingredients [2] | HB | CC | 4C086 | |
|
|
Medicinal preparations containing material or reaction products thereof with undetermined constitution [2] | HB | CC | 4C087 | |
|
|
pharmaceutical preparation having unknown structure and including materials from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine | HB | CC | 4C088 | |
|
|
Medicinal preparations containing peptides(peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergoline-based peptides A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00) [6] | HB | CC | 4C084 | |
|
|
Medicinal preparations containing antigens or antibodies (materials for immunoassay G01N 33/53) [2] | HB | CC | 4C085 | |
|
|
Cellular immunotherapy (medicinal preparations containing antigens or antibodies A61K 39/00)[2025.01] | HB | CC | 4C087 | |
|
|
Medicinal preparations obtained by treating materials with wave energy or particle radiation | HB | CC | 4C084 | |
|
|
Medicinal preparations containing active ingredients not provided for in groups A61K 31/00-A61K 41/00 [2,6] | HB | CC | 4C084 | |
|
|
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient [2] | HB | CC | 4C076 | |
|
|
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy [5] | HB | CC | 4C084 | |
|
|
Preparations for testing in vivo [3] | HB | CC | 4C085 | |
|
|
Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography [ECG] or for transcutaneous drug administration [2006.01] | HB | CC | 4C085 | |
|
|
Preparations containing radioactive substances for use in therapy or testing in vivo | HB | CC | 4C085 | |
| Indexing scheme associated with group A61K 51/00, relating to the nature of the radioactive substance.[6] | |||||
|
|
Indexing scheme associated with group A61K 51/00, relating to the nature of the radioactive substance. | HB | CC | ||
|
|
Radioactive metals [6] | HB | CC | ||
| Indexing scheme associated with group A61K 36/00, relating to plant parts with medicinal activity.[8] | |||||
|
|
Containing or obtained from roots, bulbs, tubers, corms or rhizomes [8] | HB | CC | ||
|
|
Containing or obtained from leaves [8] | HB | CC | ||
|
|
Containing or obtained from bark [8] | HB | CC | ||
|
|
Containing or obtained from seeds, nuts, fruits or grains [8] | HB | CC | ||
|
|
Containing or obtained from flowers or blossoms [8] | HB | CC | ||
|
|
Containing or obtained from stems, stalks, branches, twigs or shoots [8] | HB | CC | ||